Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Clinical trial NCT05030428 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05030428
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2027-10-13
- Enrollment
- 17004
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.